What Are Oral Retinoid Side Effects for RXLI?
At a Glance
Oral retinoids for severe Recessive X-linked Ichthyosis (RXLI) cause daily side effects like severe dryness and chapped lips. They also carry internal risks requiring routine blood tests for liver and lipid levels, and careful bone growth monitoring in children.
In this answer
5 sections
Oral retinoids, such as acitretin or isotretinoin, are powerful vitamin A derivatives that can significantly improve the severe scaling associated with Recessive X-linked Ichthyosis [1][2]. Because these medications affect the whole body, they carry a risk of serious side effects and require a major commitment to ongoing medical monitoring [3]. For this reason, dermatologists reserve oral retinoid pills exclusively for severe cases of ichthyosis that have not responded to topical treatments alone [1][4].
What to Expect: Timeline and Daily Routine
If you begin taking an oral retinoid, you will likely notice the daily side effects within the first few days to weeks, whereas significant softening and peeling of your thick scales may take several weeks to a few months to fully appear [3][2].
You will still need to continue your daily routine of applying thick moisturizers. In fact, because the medication causes widespread skin dryness, your moisturizing routine will shift from managing thick scales to managing the medication’s intense drying effects.
Common Day-to-Day Side Effects
Almost everyone who takes an oral retinoid will experience some daily side effects, which are generally related to how the drug impacts the skin and mucous membranes [5]. These effects are dose-dependent, meaning they become more intense if the dosage is increased. Common issues include:
- Mucocutaneous dryness: Severe dryness of the skin, eyes, and inside of the nose is very common [5]. You will likely need to use over-the-counter lubricating eye drops and saline nasal sprays to manage this discomfort.
- Chapped lips: Known medically as cheilitis, this is the most universal side effect of oral retinoids and usually requires the constant use of heavy lip balm throughout the day [5][3].
- Hair thinning: Some patients experience temporary hair thinning or hair loss while taking the medication, though this often improves if the dose is lowered [3].
Serious Risks and Blood Test Monitoring
Beyond dry skin, oral retinoids can cause invisible metabolic changes inside your body. To catch these changes early, your dermatologist will require routine blood tests, typically monthly when you first start, and then every few months once you are on a stable maintenance dose [6][7].
The two main internal risks monitored via blood work are:
- Liver function: Retinoids are processed by the liver and can sometimes cause inflammation or liver damage [8]. Regular blood tests check liver enzymes (ALT and AST) to ensure the organ remains healthy.
- Lipid profiles: These medications can increase the levels of fats in your blood, specifically triglycerides and cholesterol [9][10]. If triglyceride levels become too high, it can pose a risk to your cardiovascular health or pancreas.
Special Precautions for Children: Bone Toxicity
If a child is prescribed an oral retinoid for severe ichthyosis, there are additional risks related to their growing bodies. Long-term use of systemic retinoids in children has been associated with bone toxicity [11][12].
The primary concern is premature epiphyseal closure—a condition where the growth plates at the ends of the long bones fuse together too early [13][14]. If this happens, it can permanently stunt a child’s growth. Retinoids can also cause extra bone to grow where ligaments attach to the skeleton, known as hyperostosis [15]. Because of these risks, a pediatric dermatologist will closely monitor a child’s growth curve and may order baseline and periodic X-rays (such as annually, or if bone or joint pain arises) to check the health of their bones and growth plates [16][4]. Typically, doctors use the lowest possible maintenance dose in children to minimize these skeletal risks [17][18].
Family Planning and Male Fertility
Because Recessive X-linked Ichthyosis almost exclusively affects males, a very common question is whether these heavy-duty medications affect fertility or pose risks to future children.
Oral retinoids carry severe teratogenic (birth defect) warnings for female patients who take them for other skin conditions, requiring strict contraceptive protocols [19][20]. However, male patients do not face these same reproductive restrictions. The medication does not impact male fertility, and there is no clinical evidence that the trace amounts of the drug found in semen pose a risk of causing birth defects to a pregnant partner [19].
Common questions in this guide
How often do I need blood tests while taking oral retinoids for RXLI?
What are the daily side effects of taking an oral retinoid?
Can oral retinoids affect a child's bone growth?
Do oral retinoids for RXLI affect male fertility or future children?
How can I manage the intense dryness caused by oral retinoids?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.How frequently will I (or my child) need blood tests to monitor liver function and lipid levels once the dose is stable?
- 2.At what point in our treatment plan would you consider the scaling severe enough to warrant the risks of an oral retinoid?
- 3.If my child takes this medication, exactly how often will we perform X-rays to monitor their bone health and growth plates?
- 4.What specific over-the-counter lip balms, eye drops, or nasal sprays do you recommend to manage the intense dryness caused by this medication?
- 5.Are there ways to safely combine this pill with my current topical routine to allow for a lower daily dose?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (20)
- 1
Clinicopathological and management outcome in 70 patients with pityriasis rubra pilaris: A retrospective analysis.
Karaosmanoglu N, Cetinkaya PO, Yüksel İ
Indian journal of dermatology, venereology and leprology 2025; (91(S2)):S95-S101.
PMID: 40357975 - 2
Congenital Ichthyosis: A Case Treated Successfully With Acitretin.
Gulasi S
Iranian journal of pediatrics 2016; (26(5)):e2442 doi:10.5812/ijp.2442.
PMID: 28203322 - 3
Drug survival and safety profile of acitretin monotherapy in patients with psoriasis: A multicenter retrospective study.
Kara Polat A, Oguz Topal I, Aslan Kayıran M, et al.
Dermatologic therapy 2021; (34(2)):e14834 doi:10.1111/dth.14834.
PMID: 33527603 - 4
Management of pediatric psoriasis with acitretin: A review.
Subedi S, Yu Q, Chen Z, Shi Y
Dermatologic therapy 2018; (31(1)) doi:10.1111/dth.12571.
PMID: 29094450 - 5
Systemic isotretinoin therapy in the era of COVID-19.
Abdelmaksoud A, Vestita M, El-Amawy HS, et al.
Dermatologic therapy 2020; (33(4)):e13482 doi:10.1111/dth.13482.
PMID: 32358858 - 6
A retrospective study on the liver toxicity of oral retinoids in Chanarin-Dorfman syndrome.
Valette C, Jonca N, Fischer J, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV 2023; (37(10)):e1237-e1241 doi:10.1111/jdv.19235.
PMID: 37257069 - 7
Expert Consensus on the Rational Approach to Isotretinoin Usage for Effective Management of Acne: ERAISE ACNE Recommendations.
Kandhari S, Thomas J, Khunger N, et al.
Dermatology and therapy 2026; (16(6)):2607-2638 doi:10.1007/s13555-026-01681-6.
PMID: 41915360 - 8
Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies.
Menter A, Gelfand JM, Connor C, et al.
Journal of the American Academy of Dermatology 2020; (82(6)):1445-1486 doi:10.1016/j.jaad.2020.02.044.
PMID: 32119894 - 9
The Effects of Acitretin on Insulin Resistance, Glucose Metabolism, and Lipid Levels in Patients with Psoriasis.
Sachdev SS, Jamil A, Gunabalasingam P, Safdar NA
Indian journal of dermatology 2022; (67(4)):349-354 doi:10.4103/ijd.ijd_328_21.
PMID: 36578705 - 10
Apolipoproteins in Psoriasis: The Effect of Acitretin Treatment and UVB Phototherapy.
Myśliwiec H, Kozłowska D, Hodun K, et al.
Metabolites 2025; (15(3)) doi:10.3390/metabo15030196.
PMID: 40137160 - 11
Isolated hypohidrosis: pathogenesis and treatment.
Chan MMH, Lim GH, Zhao X, Tey HL
European journal of dermatology : EJD 2020; (30(6)):680-687 doi:10.1684/ejd.2020.3931.
PMID: 33262099 - 12
Safety assessment of a novel C-type natriuretic peptide derivative and the mechanism of bone- and cartilage-specific toxicity.
Yotsumoto T, Morozumi N, Nakamura R, et al.
PloS one 2019; (14(9)):e0218229 doi:10.1371/journal.pone.0218229.
PMID: 31509532 - 13
Analysis of the effects of isotretinoin on the premature epiphyseal closure in pediatric populations: a literature review.
Alazawi S, Hendriksz T
Journal of osteopathic medicine 2021; (122(1)):45-53 doi:10.1515/jom-2021-0108.
PMID: 34626532 - 14
Premature epiphyseal growth plate arrest after isotretinoin therapy for high-risk neuroblastoma: A case series and review of the literature.
Duvalyan A, Cha A, Goodarzian F, et al.
Pediatric blood & cancer 2020; (67(8)):e28236 doi:10.1002/pbc.28236.
PMID: 32386124 - 15
Untargeted Metabolomics Investigating the Intracellular Metabolic Alterations of HaCaT Cells Treated with Isotretinoin.
Zhu S, He Y, Wu L, et al.
Drug design, development and therapy 2026; (20()):585422 doi:10.2147/DDDT.S585422.
PMID: 41737990 - 16
Biochemical and histopathologic assessment of effects of acitretin on epiphyseal growth plate in rats.
Onder S, Bilgili SG, Bulut G, et al.
Postepy dermatologii i alergologii 2020; (37(3)):346-352 doi:10.5114/ada.2020.95983.
PMID: 32792874 - 17
Long-term safety and efficacy of continuous acitretin monotherapy for three children with different severe hyperkeratotic disorders in China.
Liang J, Chen P, Chen H, et al.
The Journal of dermatology 2018; (45(8)):1003-1008 doi:10.1111/1346-8138.14462.
PMID: 29756235 - 18
Pros and cons of using systemic acitretin in the paediatric population.
Sadowska M, Narbutt J, Skibińska M, Lesiak A
Postepy dermatologii i alergologii 2022; (39(1)):34-38 doi:10.5114/ada.2020.98558.
PMID: 35369612 - 19
Acne Transcriptomics: Fundamentals of Acne Pathogenesis and Isotretinoin Treatment.
Melnik BC
Cells 2023; (12(22)) doi:10.3390/cells12222600.
PMID: 37998335 - 20
Alitretinoin as a Treatment Modality for Ichthyosis in Women of Childbearing Age: A Case Series and Review of the Literature.
Clabbers J, van Oosten NV, Bolling M, et al.
Dermatology (Basel, Switzerland) 2024; (240(1)):170-177 doi:10.1159/000533934.
PMID: 37666225
This page is for educational purposes only and does not replace professional medical advice. Always discuss the risks, benefits, and monitoring requirements of oral retinoid therapy with your dermatologist.
Get notified when new evidence is published on Recessive X-linked ichthyosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.